Trials / Conditions / Node-negative Breast Cancer
Node-negative Breast Cancer
5 registered clinical trials studyying Node-negative Breast Cancer.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast Cancer NCT05150652 | Irada Ibrahim-zada | Phase 2 |
| Terminated | De-escalation Adjuvant Chemo in HER2+/ER-/node-neg Early BC Patients Who Achieved PCR After Neoadjuvant Chemo NCT04675827 | Jules Bordet Institute | Phase 2 |
| Active Not Recruiting | A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anato NCT04569747 | Dana-Farber Cancer Institute | Phase 2 |
| Terminated | A Breast Cancer Treatment Decision Aid for Women Aged 70 and Older NCT02823262 | Beth Israel Deaconess Medical Center | N/A |
| Completed | Antioxidant Supplements, Genetics and Chemotherapy Outcomes NCT03413761 | Roswell Park Cancer Institute | — |